Procathepsin D and cancer: From molecular biology to clinical applications

doi:10.5306/wjco.v1.i1.35

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4633)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

354

HTML

3444

Figures (1-4)

438

Tables (1-1)

397

Sum=4633

Nov 10, 2010 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Nov 10, 2010; 1(1): 35-40
Published online Nov 10, 2010. doi: 10.5306/wjco.v1.i1.35

Full Size Figure Download Figure

Figure 2 Level of anti-procathepsin D autoantibodies in patients with various stages of breast cancer evaluated by enzyme-linked immunosorbent assay. Average age of patients in each group varied from 31 to 69.

Citation: Vetvicka V, Vashishta A, Saraswat-Ohri S, Vetvickova J. Procathepsin D and cancer: From molecular biology to clinical applications. World J Clin Oncol 2010; 1(1): 35-40
URL: https://www.wjgnet.com/2218-4333/full/v1/i1/35.htm
DOI: https://dx.doi.org/10.5306/wjco.v1.i1.35